{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T22:13:29Z","timestamp":1780697609296,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004477","name":"Universiteit Stellenbosch","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007112","name":"University of Cape Town","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["105869"],"award-info":[{"award-number":["105869"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"Medical Research Council of South Africa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001325","name":"Cancer Association of South Africa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/17177-6"],"award-info":[{"award-number":["2015\/17177-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/08400-1"],"award-info":[{"award-number":["2018\/08400-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/02008-5"],"award-info":[{"award-number":["2019\/02008-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bcp.2021.114598","type":"journal-article","created":{"date-parts":[[2021,5,9]],"date-time":"2021-05-09T09:56:11Z","timestamp":1620554171000},"page":"114598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The palladacycle, BTC2, exhibits anti-breast cancer and breast cancer stem cell activity"],"prefix":"10.1016","volume":"190","author":[{"given":"Serah","family":"Kimani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suparna","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikponmwosa","family":"Irene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"de la Mare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Edkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"du Toit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Loos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique","family":"Blanckenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Van Niekerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia V.","family":"Costa-Lotufo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KN.","family":"ArulJothi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selwyn","family":"Mapolie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2021.114598_b0005","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1158\/1078-0432.CCR-03-0746","article-title":"A Phase I and Pharmacological Study with Imidazolium- trans- DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent","volume":"10","author":"Rademaker-lakhai","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2021.114598_b0010","doi-asserted-by":"crossref","unstructured":"B.K.K. Christian, G. Hartinger, Stefanie Zorbas-Seifried, Michael A. Jakupec, Bernd Kynast, Haralabos Zorbas, From Bench to Bedside-Preclinical and Early Clinical Development of the Anticancer Agent Indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A), J. Inorg. Biochem. 100 (2006) 891\u2013904. doi:10.1016\/j.jinorgbio.2006.02.013.","DOI":"10.1016\/j.jinorgbio.2006.02.013"},{"key":"10.1016\/j.bcp.2021.114598_b0015","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1016\/j.ejmech.2011.07.055","article-title":"Anti-cancer activity of a novel palladium(II) complex on human breast cancer cells in vitro and in vivo","volume":"46","author":"Ulukaya","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2021.114598_b0020","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0223-5234(02)01415-0","article-title":"Synthesis, crystal structure and initial biological evaluation of the new enantiomerically pure chiral palladium (II) complex trans-bis[endo-(1R)-1,7,7-trimethylbicyclo[2.2.1]-heptan-2-amino]palladium(II)dichloride","volume":"37","author":"Abu-Surrah","year":"2002","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2021.114598_b0025","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ejmech.2009.10.029","article-title":"New palladium(II) complexes bearing pyrazole-based Schiff base ligands: Synthesis, characterization and cytotoxicity","volume":"45","author":"Abu-Surrah","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2021.114598_b0030","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1021\/cr020010d","article-title":"Biochemical modulation of cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance","volume":"103","author":"Fuertes","year":"2003","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bcp.2021.114598_b0035","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/813457","article-title":"Cytotoxic effects of newly synthesized palladium(II) complexes of diethyldithiocarbamate on gastrointestinal cancer cell lines","volume":"2014","author":"Hadizadeh","year":"2014","journal-title":"Biochem. Res. Int."},{"key":"10.1016\/j.bcp.2021.114598_b0040","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1021\/jp909143b","article-title":"Design, synthesis, and biological evaluation of a new palladium(II) complex: \u03b2-lactoglobulin and K562 as targets","volume":"114","author":"Divsalar","year":"2010","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bcp.2021.114598_b0045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ardp.200900140","article-title":"Platinum and palladium-triazole complexes as highly potential antitumor agents","volume":"343","author":"Al-Masoudi","year":"2010","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bcp.2021.114598_b0050","first-page":"1","article-title":"Palladium-based chemotherapeutic agents: routes toward complexes with good antitumor activity","volume":"6","author":"Abu-Surrah","year":"2008","journal-title":"Cancer Ther."},{"key":"10.1016\/j.bcp.2021.114598_b0055","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1021\/om3006239","article-title":"Organometallic palladium complexes with a water-soluble iminophosphorane ligand as potential anticancer agents","volume":"31","author":"Carreira","year":"2012","journal-title":"Organometallics"},{"key":"10.1016\/j.bcp.2021.114598_b0060","doi-asserted-by":"crossref","first-page":"9081","DOI":"10.1039\/C6NJ01880G","article-title":"A water-soluble Pd(ii) complex with a terpyridine ligand: experimental and molecular modeling studies of the interaction with DNA and BSA; and: in vitro cytotoxicity investigations against five human cancer cell lines","volume":"40","author":"Darabi","year":"2016","journal-title":"New J. Chem."},{"key":"10.1016\/j.bcp.2021.114598_b0065","first-page":"1","article-title":"Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells","volume":"13","author":"Shibahara","year":"2013","journal-title":"BMC Cancer."},{"key":"10.1016\/j.bcp.2021.114598_b0070","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00204-002-0329-7","article-title":"Synthesis of a palladium(II)-dithiocarbamate complex: biological assay and nephrotoxicity in rats","volume":"76","author":"Trevisan","year":"2002","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bcp.2021.114598_b0075","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2174\/1871520610909030356","article-title":"Current development of Pd(II) complexes as potential antitumor agents","volume":"9","author":"Enjun Gao","year":"2009","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.bcp.2021.114598_b0080","doi-asserted-by":"crossref","unstructured":"A.C.K. and J.K. Barton, The path for metal complexes to a DNA target, Chem. Commun. 49 (2014) 3617\u20133630. https:\/\/doi.org\/10.1039\/c3cc00177f.","DOI":"10.1039\/c3cc00177f"},{"key":"10.1016\/j.bcp.2021.114598_b0085","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.bcp.2013.09.020","article-title":"A novel binuclear palladacycle complex inhibits melanoma growth in vitro and in vivo through apoptosis and autophagy","volume":"86","author":"Aliwaini","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114598_b0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.canlet.2014.11.027","article-title":"The palladacycle, AJ-5, exhibits anti-tumour and anti-cancer stem cell activity in breast cancer cells","volume":"357","author":"Aliwaini","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2021.114598_b0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-019-0139-9","article-title":"The palladacycle complex AJ-5 induces apoptotic cell death while reducing autophagic flux in rhabdomyosarcoma cells","volume":"5","author":"Bleloch","year":"2019","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bcp.2021.114598_b0100","unstructured":"A. Blanckenberg, Preparation and Characterization of Novel Palladacycles and their Evaluation as Anticancer Agents, Stellenbosch University, 2016."},{"key":"10.1016\/j.bcp.2021.114598_b0105","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jsps.2020.08.004","article-title":"Galenia africana plant extract exhibits cytotoxicity in breast cancer cells by inducing multiple programmed cell death pathways","volume":"28","author":"Mohamed","year":"2020","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.bcp.2021.114598_b0110","article-title":"Facile entry to germanate and stannate complexes [(eta)(6-arene)RuCl(eta(2-dppm)](+)[ECl3](-) (E= Ge, Sn) as potent anti-cancer agents","volume":"916","author":"Ge","year":"2020","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bcp.2021.114598_b0115","first-page":"1060","article-title":"Measuring autophagosome flux","volume":"14","author":"du Toit","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.bcp.2021.114598_b0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2184.36.s.1.6.x","article-title":"Stem cells in normal breast development and breast cancer","volume":"36","author":"Dontu","year":"2003","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bcp.2021.114598_b0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1475-2867-13-39","article-title":"Assessment of potential anti-cancer stem cell activity of marine algal compounds using an in vitro mammosphere assay","volume":"13","author":"de la Mare","year":"2013","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bcp.2021.114598_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2018.12.004","article-title":"The pyrrolopyrimidine colchicine-binding site agent PP-13 reduces the metastatic dissemination of invasive cancer cells in vitro and in vivo","volume":"160","author":"Gilson","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114598_b0135","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.9b01865","article-title":"Ring-fused diphenylchlorins as potent photosensitizers for photodynamic therapy applications. In vitro tumor cell biology and in vivo chick embryo chorioallantoic membrane studies","author":"Nascimento","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.bcp.2021.114598_b0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/17460441003605098","article-title":"Lipophilicity in drug discovery","volume":"5","author":"Warning","year":"2010","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bcp.2021.114598_b0145","first-page":"1","article-title":"Assessment of interactions between cisplatin and two histone deacetylase inhibitors in breast cancer cell lines \u2013 an isobolographic","author":"Wawruszak","year":"2015","journal-title":"Analysis"},{"key":"10.1016\/j.bcp.2021.114598_b0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biochi.2017.06.004","article-title":"Cytotoxic effect of a novel naphthylchalcone against multiple cancer cells focusing on hematologic malignancies","volume":"140","author":"Franzoni","year":"2017","journal-title":"Biochimie."},{"key":"10.1016\/j.bcp.2021.114598_b0155","doi-asserted-by":"crossref","unstructured":"A.C. Obenauf, J. Massagu\u00e9, Surviving at a distance\u00a0: organ specific metastasis, 1 (2016) 76\u201391. https:\/\/doi.org\/10.1016\/j.trecan.2015.07.009.","DOI":"10.1016\/j.trecan.2015.07.009"},{"key":"10.1016\/j.bcp.2021.114598_b0160","doi-asserted-by":"crossref","unstructured":"L.J. Geng, A.T. Alexandrou, Breast cancer stem cells: multiple capacities in tumor metastasis, Cancer Lett. 349 (2014) 1\u20137. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.canlet.2014.03.036.","DOI":"10.1016\/j.canlet.2014.03.036"},{"key":"10.1016\/j.bcp.2021.114598_b0165","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/15384047.2016.1190488","article-title":"Combination therapy targeting both cancer stem-like cells and bulk tumor cells for improved efficacy of breast cancer treatment","volume":"17","author":"Wang","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bcp.2021.114598_b0170","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1038\/sj.onc.1209735","article-title":"Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D","volume":"25","author":"Hui","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2021.114598_b0175","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s10495-017-1382-2","article-title":"Perifosine enhances bevacizumab-induced apoptosis and therapeutic efficacy by targeting PI3K\/AKT pathway in a glioblastoma heterotopic model","volume":"22","author":"Ramezani","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcp.2021.114598_b0180","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/bph.14594","article-title":"Potent effects of dioscin against hepatocellular carcinoma through regulating TP53-induced glycolysis and apoptosis regulator (TIGAR)-mediated apoptosis, autophagy, and DNA damage","volume":"176","author":"Mao","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114598_b0185","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1080\/15384047.2016.1167292","article-title":"Identification of mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme","volume":"17","author":"Senbabaoglu","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bcp.2021.114598_b0190","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.ejca.2011.06.003","article-title":"Death Receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cells","volume":"47","author":"Su","year":"2011","journal-title":"Eur. J. Cancer."},{"key":"10.1016\/j.bcp.2021.114598_b0195","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1158\/0008-5472.CAN-08-2436","article-title":"Small molecule XIAP inhibitors enhance TRAIL-Lnduced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma","volume":"69","author":"Vogler","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2021.114598_b0200","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.ejca.2011.10.013","article-title":"Inhibition of human hepatocellular carcinoma HepG2 by phthalocyanine photosensitiser PHOTOCYANINE: ROS production, apoptosis, cell cycle arrest","volume":"48","author":"Shao","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bcp.2021.114598_b0205","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.tiv.2014.02.002","article-title":"Toxicology in Vitro Involvement of extrinsic and intrinsic apoptotic pathways together with endoplasmic reticulum stress in cell death induced by naphthylchalcones in a leukemic cell line: advantages of multi-target action","volume":"28","author":"Winter","year":"2014","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.bcp.2021.114598_b0210","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","article-title":"Cell death: critical control points","volume":"116","author":"Danial","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2021.114598_b0215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bcp.2018.11.012","article-title":"The roles of ubiquitination in extrinsic cell death pathways and its implications for therapeutics","volume":"162","author":"Seo","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2021.114598_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1235-0","article-title":"Necroptosis: a regulated inflammatory mode of cell death","volume":"15","author":"Dhuriya","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bcp.2021.114598_b0225","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature14191","article-title":"Necroptosis and its role in inflammation","volume":"517","author":"Pasparakis","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2021.114598_b0230","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/cdd.2016.8","article-title":"Cancer therapy in the necroptosis era","volume":"23","author":"Su","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2021.114598_b0235","doi-asserted-by":"crossref","unstructured":"N.K. Nakaso, Y. Yoshimoto, T. Nakano, T. Takeshima, Y. Fukuhara, K. Yasui, S. Araga, T. Yanagawa, T. Ishii, Transcriptional activation of p62\/A170\/ZIP during the formation of the aggregates: possible mechanisms and the role in Lewy body formation in Parkinson\u2019s disease, Brain Res. 1012 (2004) 42\u201351. doi:10.1016\/j.brainres.2004.03.029.","DOI":"10.1016\/j.brainres.2004.03.029"},{"key":"10.1016\/j.bcp.2021.114598_b0240","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/aps.2013.23","article-title":"Autophagy modulation as a target for anticancer drug discovery","volume":"34","author":"Li","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2021.114598_b0245","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.yexcr.2014.06.010","article-title":"The chick embryo chorioallantoic membrane as a model for tumor biology","volume":"328","author":"Ribatti","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2021.114598_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-25573-8","article-title":"Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer","volume":"8","author":"Vu","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221002045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221002045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:09:11Z","timestamp":1762096151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221002045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":50,"alternative-id":["S0006295221002045"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114598","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The palladacycle, BTC2, exhibits anti-breast cancer and breast cancer stem cell activity","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114598"}}